NCT01128036 Comparison of Different Locations for Pulse Oximetry Probes in Cardiovascular (CV) Patients With Poor Peripheral Perfusion Status TERMINATED Phase N/A
NCT01102140 The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study Status TERMINATED Phase PHASE2
NCT01089036 Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients Status UNKNOWN Phase N/A
NCT01071473 Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy Status COMPLETED Phase NA
NCT01067209 Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery Status COMPLETED Phase N/A
NCT01048125 Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy Status TERMINATED Phase NA
NCT01013714 Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias Status RECRUITING Phase PHASE3
NCT01013311 Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis Status COMPLETED Phase N/A
NCT00930735 The Prognostic Significance of Fibrosis Detection in Cardiomyopathy Status UNKNOWN Phase N/A
NCT00883415 Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease Status COMPLETED Phase N/A
NCT00806390 Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol Status TERMINATED Phase PHASE4
NCT00800761 Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major Status COMPLETED Phase PHASE4
NCT00737490 Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT) Status COMPLETED Phase NA
NCT00694161 The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy Status COMPLETED Phase PHASE2
NCT00691470 Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation Status UNKNOWN Phase PHASE2/PHASE3